Tags |
|
|
Links |
|
|
Digg It - Anticipating the Audience's Reaction
Obviously, you can not know all of the things that will se
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
t off an individual person. But you can know and base your
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
actions on far more specific information about them than y
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
u probably now are using. Even if the reaction of the audi
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
nce cannot be known, try not to do anything that will dire
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
tly cause him to react negatively based on what you know t
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
be generally true.
Most people are likely to become quit
Most people are likely to become quit
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
e active in their reactions and responses, for psychologic
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
lly, they are ego-defensive as well as subjective. Either
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
onsciously or unconsciously, they will actively try to cou
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
teract anything that they find aggravating or threatening.
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
For example, if you seem superior to them in any way, they
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
will attempt to block the imagined or real superiority, pe
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
haps by not liking you or disagreeing with you, as their o
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
wn internal justification. Something as simple as your loo
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
ing like someone else they know (who perhaps once did them
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
wrong), a stereotype, or a preconceived idea could greatly
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
affect your attempt to train them.
While this may seem to
While this may seem to
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
be just simple common sense it is easy for many trainers t
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
lose perspective when speaking to a large group of people
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/40066/diggit-Anticipating-the-Audiences-Reaction.html">Anticipating the Audience's Reaction</a>
BB link (for phorums):
[url=http://www.diggit.org.ua/article/40066/diggit-Anticipating-the-Audiences-Reaction.html]Anticipating the Audience's Reaction[/url]
Related Articles:
How to Design a Good Incentive Plan
To Call Accounting Outsourcing Firm can Solve Your Problems
Bookmark it:
|